FDA Inspection 1117126 - Regenerative Biologics Inc. - February 06, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Regenerative Biologics Inc., with an inspection on February 6, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Regenerative Biologics Inc.
Inspection Date: February 6, 2020
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 075ac2fe-be00-4567-9d2e-00a473a602c1

Violation Codes1

21 CFR 1271.50(b)(1)

Full citation text and observation details available on the Dashboard.